<DOC>
	<DOC>NCT00457626</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy, safety and tolerability of long-term use (up to 18 weeks) of valsartan in children 6 months to 5 years old with hypertension.</brief_summary>
	<brief_title>An Open Label Extension Study to Evaluate the Long-term Use of Valsartan in Children 6 Months to 5 Years Old With Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>Inclusion criteria Patients who qualified and entered the core study. Patients who participated in the core study, completed period 1 and were rerandomized in period 2 and continued for at least 3 days in period 2. Exclusion criteria Patients who did not complete period 1 of the core study. Patients who were rerandomized in period 2 of core study but did not continue for =&gt; 3 days in period 2 of the core study. Patients who experienced any adverse events considered serious or drug related in the core study. Patients excluded from the core study.</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Children</keyword>
	<keyword>pediatrics</keyword>
	<keyword>High Blood Pressure</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Valsartan</keyword>
</DOC>